Credit Suisse Ag Intra Cellular Therapies, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 124,596 shares of ITCI stock, worth $9.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

124,596

Previous 118,582 5.07%

Holding current value

$9.33 Million

Previous $8.49 Million 1.53%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$64.37 - $75.65 $387,121 - $454,959	6,014 Added 5.07%	124,596 $8.62 Million
Q4 2023 Feb 08, 2024	BUY	$46.37 - $73.65 $300,199 - $476,810	6,474 Added 5.77%	118,582 $8.49 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $221,017 - $271,976	-4,243 Reduced 3.65%	112,108 $5.84 Million
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $414,890 - $504,213	7,589 Added 6.98%	116,351 $7.37 Million
Q1 2023 May 10, 2023	BUY	$43.8 - $56.99 $157,198 - $204,537	3,589 Added 3.41%	108,762 $5.89 Million

Q4 2022 Feb 13, 2023	BUY	$44.07 - $54.45 $1.22 Million - $1.51 Million	27,779 Added 35.89%	105,173 $5.57 Million
Q3 2022 Nov 10, 2022	BUY	$42.7 - $59.99 $153,677 - $215,904	3,599 Added 4.88%	77,394 $3.6 Million
Q2 2022 Aug 12, 2022	SELL	$43.0 - $65.64 $17,888 - $27,306	-416 Reduced 0.56%	73,795 $4.21 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $685,000 - $1.1 Million	17,682 Added 31.28%	74,211 $4.54 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $8.61 Million - $13.1 Million	-244,561 Reduced 81.23%	56,529 $2.96 Million
Q3 2021 Nov 12, 2021	BUY	$28.72 - $42.49 $7.28 Million - $10.8 Million	253,384 Added 531.14%	301,090 $11.2 Million
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $128,714 - $195,488	-4,393 Reduced 8.43%	47,706 $1.95 Million
Q1 2021 May 14, 2021	SELL	$30.8 - $39.51 $1.14 Million - $1.47 Million	-37,173 Reduced 41.64%	52,099 $1.77 Million
Q4 2020 Feb 12, 2021	BUY	$23.34 - $32.22 $809,431 - $1.12 Million	34,680 Added 63.53%	89,272 $2.84 Million
Q3 2020 Nov 13, 2020	SELL	$17.61 - $31.86 $118,127 - $213,716	-6,708 Reduced 10.94%	54,592 $1.4 Million
Q2 2020 Aug 12, 2020	SELL	$14.35 - $26.64 $1.22 Million - $2.26 Million	-84,934 Reduced 58.08%	61,300 $1.57 Million
Q1 2020 May 13, 2020	BUY	$12.31 - $33.12 $1.49 Million - $4.02 Million	121,436 Added 489.7%	146,234 $2.25 Million
Q4 2019 Feb 12, 2020	SELL	$7.26 - $38.49 $61,020 - $323,508	-8,405 Reduced 25.31%	24,798 $851,000
Q3 2019 Nov 12, 2019	BUY	$7.47 - $14.03 $82,289 - $154,554	11,016 Added 49.65%	33,203 $248,000
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $8,211 - $11,017	-771 Reduced 3.36%	22,187 $287,000
Q1 2019 May 14, 2019	BUY	$10.9 - $14.09 $5,493 - $7,101	504 Added 2.24%	22,958 $280,000
Q4 2018 Feb 13, 2019	BUY	$10.36 - $20.96 $5,977 - $12,093	577 Added 2.64%	22,454 $256,000
Q3 2018 Nov 13, 2018	SELL	$17.77 - $22.9 $156,713 - $201,955	-8,819 Reduced 28.73%	21,877 $474,000
Q2 2018 Aug 14, 2018	SELL	$17.33 - $23.4 $96,736 - $130,618	-5,582 Reduced 15.39%	30,696 $542,000
Q1 2018 May 15, 2018	SELL	$15.16 - $25.49 $52,650 - $88,526	-3,473 Reduced 8.74%	36,278 $763,000
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $13,784 - $16,219	966 Added 2.49%	39,751 $576,000
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $225,146 - $462,000	20,905 Added 116.92%	38,785 $612,000
Q2 2017 Aug 14, 2017	BUY	N/A	17,880	17,880 $222,000

Others Institutions Holding ITCI

# of Institutions

384

Shares Held

77.5M

Call Options Held

1.7M

Put Options Held

1.13M

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.07B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account